Beneficial Effects of Ezetimibe on Secretory Function of β-cell in db/db Mice

ZHONG Yong,JIANG Shi-Sen,WANG Jun,SHAO Jia-Qing,LU Bin,GU Ping
2012-01-01
Abstract:Aim The aim of this study was to investigate whether ezetimibe has a protective effect on β-cell function in diabetic state. Methods 8-week-old db/db mice were randomized to ezetimibe 10 mg/(kg·d),or placebo.The age-matched nondiabetic littermates db/m mice were treated with placebo as the controls.After 6 weeks' treatment,intraperitoneal glucose tolerance test and immunohistochemical staining for insulin were performed.Islet perifusion were performed to evaluate kinetics of insulin release by using islet perfusion system. Results Fasting blood glucose(FBG),total cholesterol(TC),low density lipoprotein cholesterol(LDLC) were lower in ezetimibe group than that in db/db group after 6 weeks' treatment.Ezetimibe provided an improvement of glucose tolerance and greatly rescued islet β-cell mass.Ezetimibe treatment also improved first-phase insulin response. Conclusion Ezetimibe treatment effectively improved glucose tolerance and β-cell function by significantly restored first-phase insulin secretion on db/db mice.
What problem does this paper attempt to address?